Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GlaxoSmithKline Pharmaceuticals Ltd

+ Add to Watchlist

GLXO:IN

3,273.45 INR 39.30 1.19%

As of 07:05:57 ET on 04/17/2015.

Snapshot for GlaxoSmithKline Pharmaceuticals Ltd (GLXO)

Open: 3,305.85 Day's Range: 3,240.00 - 3,318.15 Volume: 12,945
Previous Close: 3,312.75 52wk Range: 2,351.60 - 3,550.00 1-Yr Rtn: +31.38%

Stock Chart for GLXO

No chart data available.
  • GLXO:IN 3,273.45
  • 1D
  • 1M
  • 1Y
3,312.75
Interactive GLXO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLXO

Current P/E Ratio (ttm) 57.5602
Estimated P/E(12/2015) 51.2037
Relative P/E vs. SENSEX 2.9141
Earnings Per Share (INR) (ttm) 56.8700
Est. EPS (INR) (12/2015) 63.9300
Est. PEG Ratio 128.0092
Market Cap (M INR) 277,271.08
Shares Outstanding (M) 84.70
30 Day Average Volume 24,133
Price/Book (mrq) 13.9351
Price/Sale (ttm) 10.9233
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 50.0000
Dividend Ex-Date 04/03/2014
5 Year Dividend Growth 10.76%
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLXO

No data available

Company Profile & Key Executives for GLXO

Glaxosmithkline Pharmaceuticals Ltd. manufactures and distributes a wide variety of pharmaceutical drugs, veterinary products and laboratory chemicals. The Company's products include "Phexin" capsules, "Betnesol" tablets and injections, "Becoride" asthma treatment, "Betnovate" ointment, "Cetzine" antihistamine, "Zucox" and "Rizap" anti-tuberculosis products.

H B JoshipuraManaging DirectorAndrew AristidouCFO/Executive Director
H BuchExec VP:PharmaceuticalsS KhannaVP:Finance
More Company Profile & Key Executives for GLXO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil